The DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index.
Iron and cancer: recent insights
Open accessAbstract
Iron is an essential dietary element. However, the ability of iron to cycle between oxidized and reduced forms also renders it capable of contributing to free radical formation, which can have deleterious effects, including promutagenic effects that can potentiate tumor formation. Dysregulation of iron metabolism can increase cancer risk and promote tumor growth. Cancer cells exhibit an enhanced dependence on iron relative to their normal counterparts, a phenomenon we have termed iron addiction. Work conducted in the past few years has revealed new cellular processes and mechanisms that deepen our understanding of the link between iron and cancer. Control of iron efflux through the combined action of ferroportin, an iron efflux pump, and its regulator hepcidin appears to play an important role in tumorigenesis. Ferroptosis is a form of iron‐dependent cell death involving the production of reactive oxygen species. Specific mechanisms involved in ferroptosis, including depletion of glutathione and inhibition of glutathione peroxidase 4, have been uncovered. Ferritinophagy is a newly identified mechanism for degradation of the iron storage protein ferritin. Perturbations of mechanisms that control transcripts encoding proteins that regulate iron have been observed in cancer cells, including differences in miRNA, methylation, and acetylation. These new insights may ultimately provide new therapeutic opportunities for treating cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“cancer cells have a high demand for easily accessible labile Fe2+ for their survival and growth.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Wendel, A. (1981) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(81)77046-0 · Cited by 3,032
The role of iron and reactive oxygen species in cell death
Dixon, S. J., & Stockwell, B. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1416 · Cited by 2,381
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Flagged first, then by citations
1 of the 121 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 10.1371/journal.pgen.1003408 · DOI
Cited by
Sorted by citations
Items 201–300 of 515
Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer
Hou, J. Y., Lu, Z., Cheng, X.-B., Dong, R., Jiang, Y., Wu, G., Qu, G., & Xu, Y. (2022) · BMC Cancer · doi:10.1186/s12885-022-09805-9 · Cited by 22
“Discussion Ferroptosis or iron-dependent cell death can regulate tumor proliferation, invasion, and progression [29].”
BackgroundNIR-promoted ferrous ion regeneration enhances ferroptosis for glioblastoma treatment
Xue, K., Yang, R., An, Y., Ding, Y., Li, S., Miao, F., Liu, D., Chen, D., & Tang, Q. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.004 · Cited by 22
Badran, O., Cohen, I., & Bar‐Sela, G. (2024) · Cancers · doi:10.3390/cancers16244156 · Cited by 26
Homéostasie du fer et autophagie
Hamaï, A., & Mehrpour, M. (2017) · médecine/sciences · doi:10.1051/medsci/20173303012 · Cited by 24
“L’homéostasie du fer est donc très finement régulée à la fois au niveau systémique et au niveau de la cellule [1-5].”
Firmino, G. S. S., André, S. C., Hastenreiter, Z., Campos, V. K., Abdel-Salam, M. A. L., de Souza-Fagundes, E. M., & Lessa, J. A. (2019) · Inorganica Chimica Acta · doi:10.1016/j.ica.2019.119079 · Cited by 22
Shen, H., Wu, H., Sun, F., Qi, J., & Zhu, Q. (2020) · Bioengineered · doi:10.1080/21655979.2020.1866303 · Cited by 22
Oxidative Stress and Inflammation in the Liver
Lemasters, J. J., & Jaeschke, H. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch55 · Cited by 23
Modulating Nrf2 to control lipid peroxidation and ferroptosis: implications for cancer management
Tunc, R., Ateş, İ., Yılmaz, B., Medoro, A., Davinelli, S., Süzen, S., & Saso, L. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1701249 · Cited by 21
“While iron accumulation and redox imbalance can promote genomic instability and tumor growth, they also create conditions that sensitize cancer cells to ferroptosis (56).”
Deng, Z., Yang, Z., & Peng, J. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1992606 · Cited by 21
Shu, X., Zhang, Z., Yao, Z.-Y., & Xing, X. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.763697 · Cited by 21
“Iron is an essential element for the human body, and itsmetabolic disorder is involved in the occurrence and development of many diseases (Huang, 2003; Manz et al., 2016).”
BackgroundTang, X., Jiang, F., Wang, X., Xia, Y., Mao, Y., & Chen, Y. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.741726 · Cited by 21
“Cancer cells, in comparison to normal cells, have iron addiction, or an excessive reliance on iron for proliferation (9).”
BackgroundHushmandi, K., Klionsky, D. J., Aref, A. R., Bonyadi, M., Reiter, R. J., Nabavi, N., Salimimoghadam, S., & Saadat, S. H. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.05.008 · Cited by 21
“Moreover, iron is strongly correlated with the onset and expansion of tumors, and thus iron metabolism defects might result in tumor growth [37,38].”
BackgroundDjermane, R., Nieto, C., Vargas, J., Vega, M. A., & del Valle, E. M. M. (2021) · Polymer Chemistry · doi:10.1039/d1py01473k · Cited by 21
Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma
Yang, X. Y., Mei, M., Yang, J., Guo, J., Du, F., & Liu, S. (2022) · Aging · doi:10.18632/aging.204073 · Cited by 20
Aslan, A., Karapınar, H. S., Kilicel, F., Boyacıoğlu, T., Pekin, C., Toprak, Ş. S., Cihan, M., & Yılmaz, B. S. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.127108 · Cited by 20
Kontoghiorghes, G. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054970 · Cited by 20
Acker, Z. P. V., Raemdonck, G. A. V., Logie, E., Acker, S. I. V., Baggerman, G., Berghe, W. V., Ponsaerts, P., & Dewilde, S. (2019) · Cells · doi:10.3390/cells8080873 · Cited by 20
“, Sorafenib and artemisinin derivatives) [14].”
BackgroundA Systematic Review of Nanoparticle-Mediated Ferroptosis in Glioma Therapy
Jing, L., Xiao, W., Hu, Z.-X., Liu, X., & Yuan, M.-Q. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s523008 · Cited by 19
“14,15 As such, ferroptosis represents a promising novel strategy to improve the treatment and prognosis of glioma and related malignancies.”
Iron overload and mitochondrial dysfunction orchestrate pulmonary fibrosis
Li, S., Zhang, H., Chang, J., Li, D., & Cao, P. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174613 · Cited by 20
A Ferroptosis-Related lncRNA Model to Enhance the Predicted Value of Cervical Cancer
Jiang, Z., Li, J., Feng, W., Sun, Y., & Bu, J. (2022) · Journal of Oncology · doi:10.1155/2022/6080049 · Cited by 19
“Different from normal cells, cancer cells rely too much on iron for cell proliferation [11].”
BackgroundHacıoğlu, C., Kar, F., Davran, F., & Tuncer, C. (2023) · Environmental Toxicology · doi:10.1002/tox.23797 · Cited by 19
“However, the energy deficit and the increased reactive oxygen species (ROS) caused by Fenton reactions might cause cell death with enhanced autophagy through as yet fully undiscovered pathways.(5) Recently, studies have revealed that increased autophagy and lysosomal degradation followed by redox imbalance can trigger…”
BackgroundRetractedModulation of Ferroptosis by microRNAs in Human Cancer
Velkova, I., Pasino, M., Khalid, Z., Menichini, P., Martorana, E., Izzotti, A., & Pulliero, A. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13050719 · Cited by 19
“Indeed, LOXs are enzymes that contain the iron element and use it as a cofactor for catalyzing the deoxygenation of both esterified and not esterified PUFAs to produce lipid hydroperoxide in a pro-ferroptosis full picture [11,35,43].”
BackgroundFerroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities
Tranchese, R. V., Battista, S., Cerchia, L., & Fedele, M. (2024) · Biomolecules · doi:10.3390/biom14111443 · Cited by 20
“They activate long-chain fatty acids (FAs) into fatty acyl-CoA esters, serving as substrates for synthesizing membrane phospholipids and triacylglycerols, or undergoing beta-fatty acid oxidation in mitochondria for energy.”
Iron chelates in the anticancer therapy
Szlasa, W., Gachowska, M., Kiszka, K., Rakoczy, K., Kiełbik, A., Wala, K., Puchała, J., Chorążykiewicz, K., Saczko, J., & Kulbacka, J. (2021) · Chemical Papers · doi:10.1007/s11696-021-02001-2 · Cited by 19
“Iron cellular hemostasis is partially mediated by tumor suppressor genes and oncogenes (Manz et al. 2016).”
BackgroundRole of ferroptosis in gastrointestinal tumors: From mechanisms to therapies
Si, C., Zhou, X., Deng, J., Ye, S., Kong, L., Zhang, B., & Wang, W. (2022) · Cell Biology International · doi:10.1002/cbin.11804 · Cited by 18
“A N ec ro su lf o na m i‐ d e | 999 esterification to membrane phospholipids and oxidation catalyzed by ACSL4 (fatty acid metabolism intermediary) and phospholipid choline acyltransferase 3 (lpcat3, lipid remodeling), eventually lead to ferroptosis (Koppula et al., 2020; Manz et al., 2016).”
BackgroundCuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma
Luo, G., Wang, L., Zheng, Z., Gao, B., & Lei, C. (2023) · European journal of medical research · doi:10.1186/s40001-023-01137-z · Cited by 18
“Meanwhile, Ferroptosis is another type of iron-reliant cell death by reactive oxygen species (ROS) accumulation, but differs from autophagy pyroptosis, necrosis and apoptosis [15, 16].”
BackgroundQin, J., Li, Z., Su, L., Wen, X., Tang, X., Huang, M., & Wu, J. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133323 · Cited by 18
RetractedPezacki, A. T., Gonciarz, R. L., Okamura, T., Matier, C. D., Torrente, L., Cheng, K., Miller, S. G., Ralle, M., Ward, N. P., DeNicola, G. M., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2401579121 · Cited by 18
Current advances on the role of ferroptosis in tumor immune evasion
Gao, C., Zhang, H., & Wang, X. (2024) · Discover Oncology · doi:10.1007/s12672-024-01573-1 · Cited by 18
Antimony enhances c-Myc stability in prostate cancer via activating CtBP2-ROCK1 signaling pathway
Zhang, C., Lü, C., Wang, Z., Feng, G., Du, E., Liu, Y., Wang, L., Qiao, B., Xu, Y. H., & Zhang, Z. (2018) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2018.07.070 · Cited by 18
Bio-inspired melanin nanoparticles induce cancer cell death by iron adsorption
Perring, J. C., Crawshay‐Williams, F., Huang, C. T.-L., & Townley, H. E. (2018) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-018-6190-x · Cited by 17
Zhu, J., Zhao, Y., Wu, G., Zhang, X., Chen, Q., Yang, B., Guo, X., Ji, S., & Gu, K. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7465880 · Cited by 17
“Tumor cells frequently exhibit abnormal expression of FRLs, which is associated with tumor development [20, 21].”
UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation
Wang, L., Zhao, S., Wang, Y., Liu, J., & Wang, X. (2024) · BMC Cancer · doi:10.1186/s12885-024-12212-x · Cited by 17
“Ample evidence has shown that ferroptosis can be employed in cancer treatment, since tumor cells tend to accumulate a higher level of intracellular iron for supporting the hyper-proliferation [10].”
BackgroundYang, F., Sun, S., Wang, S., Guo, J., Liu, X., Ge, N., & Wang, G. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i1.1 · Cited by 18
Liu, L., Liu, Y., Zhou, X., He, H., Chen, N., Qin, Y., Sun, X., Bian, Z., Zhang, Q., Mao, L., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115188 · Cited by 16
Harnessing ferroptosis for enhanced sarcoma treatment: mechanisms, progress and prospects
Zeng, J., Zhang, X., Lin, Z., Zhang, Y., Yang, J., Dou, P., & Liu, T. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00498-3 · Cited by 16
“Decreasing the LIP and elevating ferritin levels can be instrumental in preventing ferroptosis [28].”
BackgroundTao, J., Zhou, J., Zhu, H., Xu, L., Yang, J., Mu, X., & Fan, X. L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1503064 · Cited by 16
Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients
Lu, T., Li, C., Xiang, C., Gong, Y., Peng, W., & Chen, C. (2022) · BioMed Research International · doi:10.1155/2022/7823191 · Cited by 16
“Over the past decade, researchers have identi fi ed “ iron dependence ” as a key phenotype in cancer cells with unknown mechanisms [39, 40].”
High preoperative serum ferritin predicted poor prognosis in non-metastatic colorectal cancer
Tingting, H., Di, S., Xiaoping, C., Wu, X., & Hua, D. (2017) · Saudi Medical Journal · doi:10.15537/smj.2017.3.16110 · Cited by 16
Sarno, F., Papulino, C., Franci, G., Andersen, J. H., Cautain, B., Melardo, C., Altucci, L., & Nebbioso, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01006 · Cited by 16
“Iron levels increase in cancer cells, thereby sustaining their growth and survival (Manz et al., 2016).”
BackgroundThe Complex Roles of Redox and Antioxidant Biology in CancerPreprint
Hayashi, M., Okazaki, K., Papgiannakopoulos, T., & Motohashi, H. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041546 · Cited by 16
Lactoferrin—A Regulator of Iron Homeostasis and Its Implications in Cancer
Bolesławska, I., Bolesławska-Król, N., Jakubowski, K., Przysławski, J., & Drzymała-Czyż, S. (2025) · Molecules · doi:10.3390/molecules30071507 · Cited by 15
“In addition, tumor cells can affect iron-dependent enzymes, including mitochondrial dehydrogenases In addition, tumor cells can a ff ect iron-de-pendent enzymes, including mitochondrial dehydrogenases and Krebs cycle enzymes [103]. and Krebs cycle enzymes [103].”
Nrf2--a hidden bridge linking cancer stem cells to ferroptosis
Li, Y., Tuerxun, H., Liu, X., Zhao, Y., Wen, S., Li, Y., Cao, J., & Zhao, Y. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104105 · Cited by 16
Ferroptosis: An Emerging Target for Bladder Cancer Therapy
Shan, Z., Tang, W., Shi, Z., & Shan, T. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45100517 · Cited by 18
“Given the high uptake of iron by cancer cells, ferroptosis might play a key role in tumor progress [11].”
BackgroundNechushtai, R., Rowland, L. M., Karmi, O., Marjault, H., Nguyen, T. T., Mittal, S., Ahmed, R. S., Grant, D. G., Manrique‐Acevedo, C., Morcos, F., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2405123121 · Cited by 15
Bitirim, C. V. (2021) · PeerJ · doi:10.7717/peerj.12314 · Cited by 15
Novel Insights in the Regulatory Mechanisms of Ferroptosis in Hepatocellular Carcinoma
Ma, S., Adzavon, Y. M., Wen, X., Zhao, P., Xie, F., Liu, M., & Ma, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.873029 · Cited by 15
“, 2021), and endogenous compounds such as glutathione, ubiquinone, vitamin E and selenium (Dixon et al., 2012; Homma and Fujii, 2015; Manz et al., 2016; Stockwell et al., 2017) can be used as inhibitors of ferroptosis.”
BackgroundExpression of transferrin receptor‐1 (TFR‐1) in canine osteosarcomas
Vico, G. D., Martano, M., Maiolino, P., Carella, F., & Leonardi, L. (2020) · Veterinary Medicine and Science · doi:10.1002/vms3.258 · Cited by 15
Mechanisms of Ferroptosis and Application to Head and Neck Squamous Cell Carcinoma Treatments
Li, S., Liu, Y., Li, J., Zhao, X. B., & Yu, D. (2021) · DNA and Cell Biology · doi:10.1089/dna.2021.0023 · Cited by 16
“Remaining Fe 2 + is oxidized to Fe 3 + and is discharged from the cell where it is included in further iron cycles (Manz et al. , 2016).”
Targeting ferroptosis in cancer stem cells: A novel strategy to improve cancer treatment
Wang, L., Zhu, Y., Huang, C., Pan, Q., Wang, J., Li, H., Huang, Y., Yi, G., Li, Z., Qi, S., et al. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101678 · Cited by 14
“118,129 While both chemotherapy and iron deprivation halted cell proliferation in mouse induced pluripotent stem cells, only iron deprivation suppressed stemness marker expression.”
Ferroptosis: a novel pharmacological mechanism against multiple myeloma
Shi, J., Lu, Y., Wei, W., Ma, G., Li, C., Li, L., Wang, Y., Wang, Y., Xu, R., & Cui, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1606804 · Cited by 14
NCOA4-mediated ferritinophagy: emerging role and novel therapeutic target in precision oncology
Chen, D., Jiang, X., Duan, T., Tian, Y., Zhang, J., Wang, X., & Tan, J. (2026) · Autophagy · doi:10.1080/15548627.2026.2656779 · Cited by 14
“This uncontrolled lipid peroxidation leads to loss of membrane integrity, organelle dysfunction, and ultimately, cell death through ferroptosis [9,47].”
Chen, M., Juengpanich, S., Hu, J., Topatana, W., Cao, J., Tong, C., Lin, J., & Cai, X. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i10.1042 · Cited by 14
Implication of Ferroptosis in Cholangiocarcinoma: A Potential Future Target?
Yang, M., Li, M., Lyu, Z., & Yang, Z. (2023) · Cancer Management and Research · doi:10.2147/cmar.s406150 · Cited by 15
Idei, U., Ohta, T., Yamatani, H., Seino, M., & Nagase, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411781 · Cited by 15
Wang, G., Li, J., Zhu, L., Zhou, Z., Ma, Z., Zhang, H., Yang, Y., Niu, Q., & Wang, X. (2023) · Discover Oncology · doi:10.1007/s12672-023-00756-6 · Cited by 16
Varlamova, E. G. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110344 · Cited by 16
Song, S., Zhang, G., Yao, Z., Chen, R., Liu, K., Zhang, T., Zeng, G., Wang, Z., & Liu, R. (2025) · BMC Cancer · doi:10.1186/s12885-025-13781-1 · Cited by 14
“Moreover, the response to metal ions was also a significant factor influencing the degree of tumor differentiation [36, 37].”
Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer
Shibabaw, T., Teferi, B., Molla, M. D., & Ayelign, B. (2020) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s276404 · Cited by 15
“in iron trafficking and storage, may lead to the development of to breast cancer.(3,18,22) In this review article, we provided”
BackgroundFerroportin depletes iron needed for cell cycle progression in head and neck squamous cell carcinoma
Belvin, B. R., & Lewis, J. P. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1025434 · Cited by 14
“Studies in other cancer types have implicated elevated 64 iron levels accounting for increased activity of iron containing enzymes involved in DNA 65 replication and nucleotide synthesis (22,23).”
BackgroundHong, Y., Zhang, L., Tian, X., Xiang, X., Yu, Y., Zeng, Z., Cao, Y., Chen, S., & Sun, A. (2021) · BMC Cancer · doi:10.1186/s12885-021-09076-w · Cited by 14
Elmetwalli, A. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101326 · Cited by 16
Song, B., Wen, X., Zhang, X., Liu, Q., Ma, H., Tan, M., & Yuan, J. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00144b · Cited by 14
Ferroptosis in hematological malignant tumors
Liu, Y., Du, Z., Huang, J., Li, T., Zhang, J., Li, Y., Yi, W., & Chen, C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1127526 · Cited by 13
Research Progress on Ferroptosis and Nanotechnology-Based Treatment in Triple-Negative Breast Cancer
Zhang, J., Zhang, S., Liu, M., Yang, Z., & Huang, R. (2024) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s475199 · Cited by 13
“Studies have found 13 that when the amount of iron ions in the body is overloaded, excess ferrous iron ions generate hydroxyl radicals through the Fenton reaction to cause oxidative stress, producing a large amount of reactive oxygen species (ROS) to induce iron die.”
BackgroundJia, C. L., Fu, Y., & Li, R. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s342783 · Cited by 13
“The proliferation of cancer cells showed an iron dependence compared to normal cells.(4) Some studies have found that activating the ferroptosis process in cancer cells could be a new strategy for treating tumors, especially for cancers that lack therapeutic targets.”
BackgroundSong, X., Xin, S., Zhang, Y., Mao, J., Duan, C., Cui, K., Chen, L., Li, F., Liu, Z., Wang, T., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.810272 · Cited by 14
Jayathirtha, M., Neagu, A.-N., Whitham, D., Alwine, S., & Darie, C. C. (2022) · PubMed Central · Cited by 13
Advances in the study of regulators of ferroptosis in head and neck squamous cell carcinoma (Review)
Yang, M., Guo, R., Chen, X., Song, G., & Zhang, F. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5248 · Cited by 12
“…catalyzes the production of ROS through the Fenton reaction, and ROS further promotes lipid peroxidation and causes lipid peroxide aggregation, which induces ferroptosis (17). cancer cells are more iron‑dependent compared to normal cells (18), and some cancer cells exhibit iron ion aggrega‑ tion.”
Engineering Iron-Based Nanomaterials for Breast Cancer Therapy Associated with Ferroptosis
Wei, R., Fu, G., Li, Z., Liu, Y., & Xue, M. (2024) · Nanomedicine · doi:10.2217/nnm-2023-0270 · Cited by 12
Rozenberga, L., Bloch, W. M., Gillam, T. A., Lancaster, D. G., Skinner, W. M., Krasowska, M., Blencowe, A., & Beattie, D. A. (2024) · ACS Applied Polymer Materials · doi:10.1021/acsapm.4c00111 · Cited by 12
Piccolo, M., Russo, C., Arciuolo, V., Ferraro, M. G., Abbate, V., Porzio, A. D., Cinquegrana, E., Leva, F. S. D., Pagano, B., Randazzo, A., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01665 · Cited by 12
Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment
Ravari, N. R., Sadri, F., Mahdiabadi, M. A., Mohammadi, Y., Ourang, Z., & Rezaei, Z. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1522873 · Cited by 14
Cai, Y., Wu, S., Jia, Y., Pan, X., & Li, C. (2022) · Journal of Immunology Research · doi:10.1155/2022/1249290 · Cited by 12
“Cancer cells become addicted to iron, which is a process known as iron addiction [15, 16].”
Xia, W., Zeng, C., Zheng, Z., Huang, C., Yu, Z., & Bai, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.844759 · Cited by 12
“Dysfunction of iron metabolism is associated with tumorigenesis and tumor cell proliferation (Manz et al., 2016).”
BackgroundControl of Intracellular Molecular Networks Using Algebraic Methods
Vieira, L. S., Laubenbacher, R., & Murrugarra, D. (2019) · Bulletin of Mathematical Biology · doi:10.1007/s11538-019-00679-w · Cited by 11
“It is well accepted that iron metabolism is deregulated in several cancers [42,26].”
BackgroundTherapeutic efficacy of ferroptosis in the treatment of colorectal cancer (Review)
Guo, Z., Zhuang, H., & Shi, X. (2024) · Oncology Letters · doi:10.3892/ol.2024.14697 · Cited by 13
“The results of a previous study revealed that cancer cells require higher levels of iron than healthy cells, and are more susceptible to iron depletion, also known as iron addiction (61).”
BackgroundArsenic induces ferroptosis in HTR-8/SVneo cells and placental damage
Dong, J., Hu, Y., Liu, S., Liu, W., Zhu, Q., Liu, S., Zhang, N., Liao, C., & Jiang, G. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.176885 · Cited by 11
Wang, X., Liu, T., Fei, Y., Zhang, S., Yang, Y., Chen, Z., Zhu, R., Deng, S., Zhang, T., Wu, D., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.07.013 · Cited by 11
Serum ferritin and primary lung cancer
Chen, Z., Zhu, B., Ou, C., & Li, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.21518 · Cited by 11
“SF has the ability to store iron [5], participate in inflammation and infection [7–10], participate in cancer and other functions [1, 2, 15].”
BackgroundTrevisani, F., Floris, M., Vago, R., Minnei, R., & Cinque, A. (2022) · Cells · doi:10.3390/cells11101658 · Cited by 11
“With respect to what happen in other pathological processes, cancer cells have an increased iron avidity due to the necessity of rapidly proliferating and are dramatically more sensible to iron depletion; on the other hand, increasing the intracellular iron promotes tumor cell death through induction of ferroptosis [1…”
BackgroundYu, L., Gao, Z., Li, Z., Liu, P., Gao, Y., & Liang, G. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05267-z · Cited by 11
“Cancer cells require high iron concentrations for their rapid proliferation, suggesting that they are more vulnerable to ferroptosis than normal cells (Manz et al. 2016; Li and Li 2020).”
BackgroundPlaneta, K., Setkowicz, Z., Janik-Olchawa, N., Matusiak, K., Ryszawy, D., Dróźdż, A., Janeczko, K. J., Ostachowicz, B., & Chwiej, J. G. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00648 · Cited by 11
Ovotransferrin—Multifunctional protein: Structure, bioactivity, and industrial potential
Fijałkowski, P., Pryshchepa, O., van Eldik, R., & Pomastowski, P. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144810 · Cited by 10
Lysosome as a Chemical Reactor
Dharmasivam, M., & Kaya, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311581 · Cited by 11
“First, cancer cells often exhibit dysregulated iron metabolism, a phenomenon described as “iron addiction” [104].”
Singh, G., Gupta, S., Pawan, Mohit, M., Diksha, D., Saini, I., Vikas, V., Mohan, B., & Soni, S. (2023) · New Journal of Chemistry · doi:10.1039/d3nj00105a · Cited by 10
Zhang, A., Liu, K., Liang, X., Li, H., Fu, X., Zhu, N., Li, F., & Yang, J. (2023) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2023.102700 · Cited by 10
Mitochondrial classic metabolism and its often-underappreciated facets
Moura, J. P., Oliveira, P. J., & Urbano, A. M. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167839 · Cited by 10
Wang, X., Duan, W., Ma, Z., Wen, H., Mao, X., & Liu, C. (2025) · Cancer & Metabolism · doi:10.1186/s40170-025-00387-1 · Cited by 10
Golbashirzadeh, M., Heidari, H. R., & Khosroushahi, A. Y. (2022) · Gene Reports · doi:10.1016/j.genrep.2022.101614 · Cited by 10
Wang, Y., Li, C., Zhuo, J., Hui, H., Zhou, B., & Tian, J. (2022) · Molecular Imaging and Biology · doi:10.1007/s11307-022-01774-6 · Cited by 10
Mechanistic Development of Cancers Associated with Processed Meat Products: A Review
Bedale, W. A., Milkowski, A. L., Czuprynski, C. J., & Richards, M. P. (2023) · Meat and Muscle Biology · doi:10.22175/mmb.15762 · Cited by 11
Fat and hepatocellular carcinoma
Balsano, C., Porcu, C., Sideri, S., & Tavolaro, S. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.51 · Cited by 10
Dissolution factors and oxidative potential of acid soluble irons from chlorite mineral particles
Xie, T., Lü, S., Rao, L., Zhang, L., Wang, X., Wang, W., & Wang, Q. (2021) · Atmospheric Environment · doi:10.1016/j.atmosenv.2021.118436 · Cited by 10
Věžník, J., Konhefr, M., Fohlerová, Z., & Lacina, K. (2021) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2021.111561 · Cited by 10
HIF1α/miR-146α/TRAF6/NF-κB axis modulates hepatic iron overload-induced inflammation
Mo, F., Tang, Y., Shen, H., Wu, L., Liu, Q., Nie, S., Li, M., & Ling, C. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109499 · Cited by 9
Roufosse, B., Serbu, C., Marschner, C., Prince, S., & Blom, B. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116528 · Cited by 9
Razi, S., Khojini, J. Y., Norioun, H., Hayati, M. J., Naseri, N., Tajbakhsh, A., & Hayat, S. M. G. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111503 · Cited by 9
Role of ferroptosis in atrial fibrillation: a review
Fan, S., Hu, Y., & Shi, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1362060 · Cited by 9
“By engul fi ng ferritin through phagocytosis, autophagy elevates intracellular free iron levels, further promoting ferroptosis (Manz et al., 2016).”
Qian, L.-H., Wen, K.-L., Guo, Y., Liao, Y.-N., Li, M.-Y., Li, Z., Li, S., & Nie, H. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02088-y · Cited by 9
“Tumor cells, being more metabolically active, are highly susceptible to oxidative stress-induced cell death, which presents an opportunity for ferroptosis-based therapies to selectively target cancer cells while sparing normal tissues [9, 10].”
Metadata
- Authors
- Manz, D. H., Blanchette, N. L., Paul, B. T., Torti, F. M., & Torti, S. V.
- Affiliations
- Department of Molecular Biology and Biophysics
- UConn Health (US)
- Corresponding author
- Torti, Suzy V.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2016-02-18
- Volume
- 1368
- Issue
- 1
- Pages
- 149-161
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- PMC
- PMC4870095
- OpenAlex
- W2275201610
- Cited by
- 507
- References
- 121
- Citations by year
- 2026: 24 · 2025: 49 · 2024: 69 · 2023: 78 · 2022: 66 · 2021: 77 · 2020: 46 · 2019: 43 · 2018: 31 · 2017: 14 · 2016: 10
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of the New York Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- S.V.T (CA188025)
- F.M.T (CA171101)
- D.H.M. (DE021989)
- U.S. National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- iron metabolism, cancer, ferroptosis, ferroportin, hepcidin, iron efflux, reactive oxygen species, glutathione depletion, GPX4, ferritinophagy, ferritin degradation, tumor microenvironment, epigenetic regulation, microRNA, DNA methylation, histone acetylation, cancer therapy
- MeSH terms
- Ferroportin, Animals, Humans, Iron, Neoplasms, Reactive Oxygen Species, Iron Overload, Cation Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review